查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722540

2025 年至 2033 年器官晶片市场报告（按产品、类型、应用、最终用途和地区划分）

Organ-on-chip Market Report by Offering, Type, Application, End Use, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球器官晶片市场规模达 7,840 万美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 6.51 亿美元，2025-2033 年期间的成长率 (CAGR) 为 25.19%。该市场受到其在加强医药研发方面的关键作用的推动，受到技术进步、协作努力以及透过医学研究中更准确和人道的替代方案减少动物试验的监管和道德日益重视的刺激。

器官晶片市场分析：

主要市场驱动因素：由于製药和生物技术领域对更准确、更符合道德的研究方法的需求，器官晶片市场正在迅速扩张。

主要市场趋势：3D 生物列印和微流体等技术进步正在彻底改变器官晶片模型，提高其准确性和适用性。

地理趋势：北美引领市场，并得到强大的研究基础设施和积极的监管政策的支持；然而，由于对生物技术的投资不断增加，欧洲和亚太地区正在迅速赶上。

竞争格局：器官晶片产业的主要市场参与者包括 Allevi Inc.、Altis Biosystems、AxoSim、BiomimX Srl、Elveflow、Emulate Inc.、InSphero、MIMETAS、Nortis Inc.、TARA Biosystems Inc.、TissUse GmbH. 等。

挑战与机会：虽然技术复杂性和高成本带来了挑战，但个人化医疗的日益增长和多器官模型的扩展为器官晶片市场带来了巨大的机会。

器官晶片市场趋势：

加强药物研发

器官晶片的市场潜力大大增加，因为它可以显着促进药物开发和发现。与传统的二维细胞培养和动物模型相比，这些技术可以更精确地模拟人体器官的反应，有助于减少药物测试和开发所需的时间。因此，这项创新提供了无与伦比的预测准确性，对于减少药物研发过程中的时间、成本和失败率至关重要。因此，製药机构开始将器官晶片技术整合到其研发流程中，以缩小差距，从而促进个人化和精准医疗的发展并提高治疗成功率。此外，这种转变有望使许多药物获得快速批准，从而部分弥补那些在最后阶段失败的药物的成本。

技术创新与合作

持续的技术进步是推动器官晶片产业变革的主要动力之一。製造能够同时复製多个器官系统功能的晶片是一种更完整的分析工具，涵盖了临床前测试的第一阶段，并使临床试验更贴近人群。正在进行的发明包括结合微流体技术、多维结构内的细胞 3D 列印以及自动成像，从而提高器官晶片系统的功能性和可扩展性。此外，生物技术公司、研究机构和技术专家之间的合作形成了跨学科研究的策略环境，从而推动了该领域的快速发展。这些合作对于克服技术问题和改进应用以及促进毒性物质测试、疾病建模和精准医疗等各个领域至关重要。例如，器官晶片(OOC) 技术透过提供更准确的预测模型彻底改变了传统的体外 ADME 和毒性测试，促进了药物开发，预计每年的成长率为 15%。 OOC 平台结合多器官系统，增强了药物动力学和药效学研究，深入了解了药物分子的时间和剂量依赖性作用。根据器官晶片市场收入，这些先进技术预计到 2025 年市场规模将达到 2.2 亿美元，其精确的流量控制和快速的样品处理优于传统的 2D 培养，使其成为功效研究和毒性评估所必需的。

监管与道德转变

有关在科学研究中应用动物的伦理问题和更严格的规定也刺激了器官晶片产业的发展。世界各地的机构和部门开始认识到这些技术的价值，它们可以提供比动物模型更相关的资料。这正是美国食品药物管理局的器官晶片计划等项目所推动的。因此，这种转变与公众和政府日益推崇的动物友善调查技术是一致的。器官晶片技术不仅符合更高的监管标准，而且在伦理上也是合理的，因为它可以推动向更人性化和科学先进的研究技术的范式转移。这种伦理立场在器官晶片设备用于研发的广泛认可中发挥越来越重要的作用。

器官晶片市场细分：

以提议分手：

  • 产品
  • 服务

按类型分列：

  • 肝
  • 心
  • 肺
  • 肾
  • 其他的

隆拥有行业最大份额

根据器官晶片市场趋势，肺晶片因其在呼吸研究和药物发现中的高度应用而成为最受关注的晶片。此技术适用于模拟人体肺部的复杂结构和功能，为呼吸系统疾病、药物反应评估和吸入物质毒性评估提供动态平台。它在加速针对气喘和慢性阻塞性肺病（COPD）等不同肺部疾病的个人化治疗发展过程中的作用得到了真正的强调。肺晶片模型可以更可靠、更符合道德地取代动物试验，从而向当局保证药物的有效性和安全性，这是成功进入市场的先决条件。这使得药物研发和生物技术成为该领域的领导角色，并持续增加器官晶片的市场份额。

按应用分类：

  • 生理模型开发
  • 药物研发
  • 毒理学研究

药物研发占据主要市场领域

根据器官晶片市场概况，药物发现是药物开发所有阶段中最大的部分。这是因为该部门拥有开发药品流程的关键转型方式。器官晶片系统可以模拟人体器官在各种条件下的反应，而这在以前是不可能的，这使得科学家能够对潜在药物进行早期筛选。电脑的这种能力使我们能够成功地估计这些药物将如何受到人体组织的影响，从而朝着功效和安全性测试过程的正确方向迈出了一步。因此，药物研发时间大大缩短，临床试验成本和风险降低。製药公司对这些技术的广泛利用表明，该领域存在着巨大的机会，不仅可以加快药物研发速度，还可以降低成本，并符合更好的安全性和有效性监管要求。

依最终用途分类：

  • 製药和生物技术公司
  • 学术和研究机构
  • 化妆品产业
  • 其他的

製药和生物技术公司在市场上占据明显主导地位

製药和生物技术公司占据最大的市场份额。这种优势主要是由于这些产业的药物发现和开发阶段微器官模型的使用增加所致。器官晶片公司利用技术复製人体功能及其反应，其水平比使用动物实验和二维细胞培养的传统方法更高。提高匹配人体器官功能和在实验室环境中相互作用的能力，可以在开发的早期阶段更好地检测药物的功效和毒性。它不仅提高了临床试验成功的可能性，而且还减少了新药商业化过程中所需的时间和成本。由于製药和生物技术公司不断寻找创新方法来加速研发过程，器官晶片技术的利用预计将持续增加，使该领域成为市场上最大的领域，并创造积极的器官晶片市场前景。

按地区划分：

  • 北美洲
  • 美国
  • 加拿大
  • 亚太
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 印尼
  • 其他的
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他的
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他的
  • 中东和非洲

北美引领市场，占据器官晶片最大市场份额

该报告还对所有主要区域市场进行了全面的分析，包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。根据报告，北美是器官晶片最大的区域市场。

根据器官晶片市场报告，这里最大的市场是北美。这一优势源于强大的研究基础设施、对生物技术和製药行业的良好资助以及政府和私营部门对创新医疗解决方案的模范支持。领先的大学和研究机构的存在进一步巩固了北美在市场上的自信领导地位，这些大学和研究机构始终推动着医学领域的前沿发展，而技术上对器官晶片的需求也日益增加。除此之外，该领域还培育了现有的监管框架，为药物开发和个人化医疗（包括器官晶片）的尖端工具提供了大量采用机会。这些经济实体的主导地位推动了其他参与者创新此类技术的开发和部署，从而促进了该地区在全球市场的突出地位。这种积极且先进的兽医系统提供了器官晶片市场成长模型，使得这些模型可用于医学研究和药物测试。

竞争格局：

市场研究报告也对市场竞争格局进行了全面的分析。也提供了所有主要公司的详细资料。器官晶片行业的一些主要市场参与者包括：

  • Allevi公司
  • 阿尔蒂斯生物系统公司
  • AxoSim
  • BiomimX有限公司
  • 埃尔夫弗洛
  • 模拟公司
  • InSphero
  • 米梅塔斯
  • 诺蒂斯公司
  • TARA生物系统公司
  • TissUse 有限公司

（请注意，这只是关键参与者的部分列表，完整列表在报告中提供。）

器官晶片产业的主要参与者透过研发、合作、併购等不同方式不断改进和拓宽其技术储备。根据器官晶片的最新发展，企业的目标是开发更具体、更通用的器官晶片模型，能够更精确地模拟人体生理机能，用于药物测试和疾病建模。这项务实的合作不仅有助于新技术的快速产品化，还能拓宽微流控系统在个人化医疗、安全药理学、复杂生物学研究等领域的应用范围，进而巩固其市场地位。根据器官晶片市场预测，与製药公司、学术机构和技术提供商的策略合作正在为市场创造积极的前景。

本报告回答的关键问题

  • 2024 年全球器官晶片市场规模是多少
  • 2025-2033年全球器官晶片市场预计成长率是多少
  • 推动全球器官晶片市场的关键因素有哪些
  • COVID-19 对全球器官晶片市场有何影响
  • 全球器官晶片市场按类型划分如何？
  • 根据应用，全球器官晶片市场如何划分
  • 根据最终用途，全球器官晶片市场如何划分
  • 全球器官晶片市场的主要区域有哪些
  • 全球器官晶片市场的主要参与者/公司有哪些

本报告回答的关键问题

  • 2024 年全球器官晶片市场规模？ 2025 年至 2033 年期间全球器官晶片市场预期成长率为何？
  • 推动全球器官晶片市场发展的关键因素有哪些？
  • COVID-19 对全球器官晶片市场有何影响？
  • 根据类型，全球器官晶片市场是如何分布的？
  • 根据应用，全球器官晶片市场如何分布？
  • 根据最终用途，全球器官晶片市场如何分布？
  • 全球器官晶片市场的主要区域有哪些？
  • 全球器官晶片市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球器官晶片市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依发行

  • 产品
  • 服务

第七章：市场区隔：依类型

  • 肝
  • 心
  • 肺
  • 肾
  • 其他的

第 8 章：市场区隔：按应用

  • 生理模型开发
  • 药物研发
  • 毒理学研究

第 9 章：市场区隔：最终用途别

  • 製药和生物技术公司
  • 学术和研究机构
  • 化妆品产业
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Allevi Inc.
    • Altis Biosystems
    • AxoSim
    • BiomimX Srl
    • Elveflow
    • Emulate Inc.
    • InSphero
    • MIMETAS
    • Nortis Inc.
    • TARA Biosystems Inc.
    • TissUse GmbH
Product Code: SR112025A5498

The global organ-on-chip market size reached USD 78.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 651.0 Million by 2033, exhibiting a growth rate (CAGR) of 25.19% during 2025-2033. The market is driven by its critical role in enhancing pharmaceutical R&D, stimulated by technological advancements, collaborative efforts, and increasing regulatory and ethical emphasis on reducing animal testing through more accurate and humane alternatives in medical research.

Organ-on-chip Market Analysis:

Major Market Drivers: The organ-on-chip market is expanding rapidly, driven by the need for more accurate and ethical research methods in pharmaceuticals and biotechnology.

Key Market Trends: Technological advancements such as 3D bioprinting and microfluidics are revolutionizing organ-on-chip models, increasing their accuracy and applicability.

Geographical Trends: North America leads the market, supported by robust research infrastructure and proactive regulatory policies; however, Europe and Asia-Pacific are quickly catching up due to rising investments in biotech.

Competitive Landscape: Some of the major market players in the organ-on-chip industry include Allevi Inc., Altis Biosystems, AxoSim, BiomimX S.r.l., Elveflow, Emulate Inc., InSphero, MIMETAS, Nortis Inc., TARA Biosystems Inc., TissUse GmbH., etc. among many others.

Challenges and Opportunities: While technological complexities and high costs pose challenges, the growing shift towards personalized medicine and the expansion into multi-organ models present significant organ-on-chip market opportunities.

Organ-on-chip Market Trends:

Pharmaceutical Research and Development Enhancement

The organ-on-chip market potential is greatly increased because it can dramatically enhance drug development and discovery. These techniques provide a more precise simulation of how human organs respond compared to conventional 2D cell cultures, and animal models and hence they help to reduce the time taken in drug testing and development. This innovation, thus, offers unparalleled prediction accuracy, essential for decreasing the duration, cost, and failure rates during drug discovery. As a result, pharmaceutical organizations are starting to integrate organ-on-chip technologies into their R&D processes to narrow the gap, leading to the advancement of personalized and precise medicine and higher therapeutic success rates. Besides, this shift produces the prospect of many quick drug approvals which partly cover the cost of those that failed in the final stage.

Technological Innovations and Collaborations

Continuous technological advancements are one of the major stimuli that are transforming the organ-on-chip industry. The manufacturing of chips capable of replicating several organ systems' functionalities at the same time is a more complete analysis tool, covering the first stage of preclinical testing and bringing clinical trials closer to the population. The inventions being made include incorporating microfluidics, 3D printing of cells within multi-dimensional structures, and automated imaging which allows for better functionality and scalability of organ-on-chip systems. Furthermore, associations between biotech firms, research institutions, and technology specialists have formed a strategic environment for cross-disciplinary studies that, in turn, results in fast improvements in this field. These collaborations are vital to overcoming technical issues and improving applications, as well as promoting various sectors like toxic things testing, disease modeling, and precision medicine. For instance, Organ-on-chip (OOC) technology revolutionizes traditional in vitro ADME and toxicity tests by offering a more accurate predictive model, enhancing drug development with an estimated growth rate of 15% annually. Incorporating multi-organ systems, OOC platforms enhance pharmacokinetic and pharmacodynamic studies, providing insights into the time and dose-dependent effects of drug molecules. Based on organ-on chip market revenue, these advanced technology, projected to reach a market size of $220 million by 2025, outperforms conventional 2D cultures with its precise flow control and rapid sample processing, making it essential for efficacy studies and toxicity evaluations.

Regulatory and Ethical Shifts

Ethical issues and stricter regulations concerning the application of animals in scientific research are additionally stimulating the growth of the organ-on-chip industry. Agencies and departments all around the world are coming to recognize the value of these technologies in providing more relevant data than animal models. This is what is being promoted by endeavors such as the USFDA's Organ-on-Chip program. Therefore, this transition is consistent with the growing public and governmental push for animal-friendly investigation techniques. Organ-on-chip technologies, not only qualifying for higher regulatory standards, are also ethically warranted, since they can promote a paradigm shift towards more human and scientifically advanced research techniques. This ethical standpoint is getting an increasing role in wider approval for organ-on-chip devices to be used in research and development.

Organ-on-chip Market Segmentation:

Breakup by Offering:

  • Products
  • Services

Breakup by Type:

  • Liver
  • Heart
  • Lung
  • Kidney
  • Others

Lung holds the largest share of the industry

According to the organ-on-chip market trend, the lung-on-chip is the most expanded due to its high application in respiratory studies and drug discovery. This technology is suitable for modeling the complex structure and function of the human lung to provide a dynamic platform for respiratory diseases, drug response evaluation, and inhaled substances toxicity assessment. Its role in the process of speeding up the development of personalized therapies for different lung diseases, such as asthma and chronic obstructive pulmonary disorder (COPD), is truly emphasized. Lung-on-chip model leads to a more reliable and ethical replacement of animal testing, hence the assurance of drug efficacy and safety to the authorities, which is a prerequisite for successful market entry. This shifts drug discovery and biotechnology to the leadership role in this area, continuing and increasing the organ-on-chip market share.

Breakup by Application:

  • Physiological Model Development
  • Drug Discovery
  • Toxicology Research

Drug discovery represents the leading market segment

As per the organ-on-chip market overview, drug discovery is the largest segment for all phases of drug development. This is because the segment has such a key transforming way of developing the processes of pharmaceutical products. Organ-on-chip systems can mimic human organs' responses under various conditions in a way that otherwise would be impossible, allowing scientists to do early screenings for a prospective drug. This ability of the computer successfully enables us to estimate how those drugs will be affected by the human tissues, which in turn creates a step in the right direction of the efficacy and safety test process. It therefore follows that the drug discovery time frame is greatly shortened, and the clinical trial costs and risk become lower. The broadening utilization of these technologies by a pharmaceutical company indicates a great opportunity in this area to make drug hunting faster but not only, less costly and in line with better regulatory requirements for safety and effectiveness.

Breakup by End Use:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Cosmetics Industry
  • Others

Pharmaceutical and biotechnology companies exhibit a clear dominance in the market

The pharmaceutical and biotechnology companies account for the largest market share. This superiority is mainly caused by the increased usage of micro-organ models in the drug discovery and development phases of these industries. The organ-on-chip companies use technology to copy human body functions and its responses to a higher level than conventional methods which use animal experimenting and 2D cell cultures. Improved capacities to match human organ functions and interact in a laboratory setting provide better detection of drug efficacy and toxicity at an early stage of development. It not only improves the prospects of success in the clinical trials but also decreases the time and cost involved in the process of commercialization of a new drug. Being that pharmaceutical and biotechnology company are constantly in search of inventive ways that will accelerate the research and development process, the utilization of organ-on-chip technologies is anticipated to keep increasing, therefore making this segment the largest one in the market and creating a positive organ-on-chip market outlook.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest organ-on-chip market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for organ-on-chip.

According to the organ-on-chip market report, the largest segment here is North America. This superiority comes from a strong research infrastructure, good funding of the biotechnology and pharmaceutical industry, and the exemplary support given to innovative healthcare solutions by the government and the private sector North American confident leadership in the market is further fortified by the existence of leading universities and research institutions that always drive the frontiers of the medical fieldwork with the Increasing organ-on-chip demand in technologies. Other than that, the area fosters an already existing regulatory framework that provides high adoption opportunities of cutting-edge tools for drug development and personalized medicine which include organ-on-chip. The dominance of these economic entities is what pushes other players to innovate the development and deployment of such technologies contribute to the regional prominence in the global market. This active and advanced veterinary system provides organ-on-chip market growth models which makes these models in use in medical research and pharmaceutical testing.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the organ-on-chip industry include:

  • Allevi Inc.
  • Altis Biosystems
  • AxoSim
  • BiomimX S.r.l.
  • Elveflow
  • Emulate Inc.
  • InSphero
  • MIMETAS
  • Nortis Inc.
  • TARA Biosystems Inc.
  • TissUse GmbH

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Major players in the organ-on-chip industry keep improving and broadening their technological arsenals by different means, including research and development, cooperation, and mergers and acquisitions. According to organ-on-chip recent developments businesses aim to develop more specific and versatile organ-on-chip models capable of simulating human physiology more precisely for drug testing and disease modeling. The pragmatic cooperation is responsible for the quick product commercialization of new technologies in addition to broadening the microfluidic systems' application scope in personalized medicine, safety pharmacology, and complex biological research, which consequently fortifies their market positions. According to the organ-on-chip market forecast, strategic collaborations with pharmaceutical companies, academic institutions, and technology providers are creating a positive outlook for the market.

Key Questions Answered in This Report

  • 1.What was the size of the global organ-on-chip market in 2024?
  • 2.What is the expected growth rate of the global organ-on-chip market during 2025-2033?
  • 3.What are the key factors driving the global organ-on-chip market?
  • 4.What has been the impact of COVID-19 on the global organ-on-chip market?
  • 5.What is the breakup of the global organ-on-chip market based on the type?
  • 6.What is the breakup of the global organ-on-chip market based on the application?
  • 7.What is the breakup of the global organ-on-chip market based on the end use?
  • 8.What are the key regions in the global organ-on-chip market?
  • 9.Who are the key players/companies in the global organ-on-chip market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Organ-on-chip Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Offering

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Liver
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Heart
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Lung
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Kidney
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Physiological Model Development
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Discovery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Toxicology Research
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cosmetics Industry
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Allevi Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Altis Biosystems
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 AxoSim
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 BiomimX S.r.l.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Elveflow
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Emulate Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 InSphero
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 MIMETAS
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Nortis Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 TARA Biosystems Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 TissUse GmbH
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Organ-on-chip Market: Major Drivers and Challenges
  • Figure 2: Global: Organ-on-chip Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Organ-on-chip Market: Breakup by Offering (in %), 2024
  • Figure 5: Global: Organ-on-chip Market: Breakup by Type (in %), 2024
  • Figure 6: Global: Organ-on-chip Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Organ-on-chip Market: Breakup by End Use (in %), 2024
  • Figure 8: Global: Organ-on-chip Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Organ-on-chip (Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Organ-on-chip (Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Organ-on-chip (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Organ-on-chip (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Organ-on-chip (Liver) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Organ-on-chip (Liver) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Organ-on-chip (Heart) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Organ-on-chip (Heart) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Organ-on-chip (Lung) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Organ-on-chip (Lung) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Organ-on-chip (Kidney) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Organ-on-chip (Kidney) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Organ-on-chip (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Organ-on-chip (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Organ-on-chip (Physiological Model Development) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Organ-on-chip (Physiological Model Development) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Organ-on-chip (Drug Discovery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Organ-on-chip (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Organ-on-chip (Toxicology Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Organ-on-chip (Toxicology Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Organ-on-chip (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Organ-on-chip (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Organ-on-chip (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Organ-on-chip (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Organ-on-chip (Cosmetics Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Organ-on-chip (Cosmetics Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Organ-on-chip (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Organ-on-chip (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia-Pacific: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia-Pacific: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Organ-on-chip Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Organ-on-chip Market: Breakup by Country (in %), 2024
  • Figure 85: Middle East and Africa: Organ-on-chip Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Global: Organ-on-chip Industry: SWOT Analysis
  • Figure 87: Global: Organ-on-chip Industry: Value Chain Analysis
  • Figure 88: Global: Organ-on-chip Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Organ-on-chip Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Organ-on-chip Market Forecast: Breakup by Offering (in Million USD), 2025-2033
  • Table 3: Global: Organ-on-chip Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 4: Global: Organ-on-chip Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Organ-on-chip Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 6: Global: Organ-on-chip Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Organ-on-chip Market: Competitive Structure
  • Table 8: Global: Organ-on-chip Market: Key Players